Advertisement
03/16/2022

Alembic’s Aleor gets FDA OK for generic Nystatin, Triamcinolone Acetonide

Nystatin and Triamcinolone Acetonide are used for the treatment of cutaneous candidiasis, which is an infection of the skin and nails caused by the candida fungus.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Alembic's joint venture, Aleor Dermaceuticals has received the Food and Drug Administration’s clearance for generic Nystatin and Triamcinolone Acetonide ointment.

The medication is used for the treatment of cutaneous candidiasis, which is an infection of the skin and nails caused by the candida fungus.

[Read more: Alembic launches generic Anafranil]

The product is the generic of Taro’s Nystatin and Triamcinolone Acetonide ointment.

Nystatin and Triamcinolone Acetonide ointment has an estimated market value of $4 million for the 12-month period ending December 2021, according to IQVIA.

[Read more: Alembic obtains FDA nod for 2 generics]

    Advertisement
    Advertisement